PT1049487E - Tratamento de porfiria aguda interminente (pai) e outras doencas porfiricas - Google Patents
Tratamento de porfiria aguda interminente (pai) e outras doencas porfiricasInfo
- Publication number
- PT1049487E PT1049487E PT99906067T PT99906067T PT1049487E PT 1049487 E PT1049487 E PT 1049487E PT 99906067 T PT99906067 T PT 99906067T PT 99906067 T PT99906067 T PT 99906067T PT 1049487 E PT1049487 E PT 1049487E
- Authority
- PT
- Portugal
- Prior art keywords
- porphyria
- enzyme
- treatment
- pbgd
- analogue
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/43—Enzymes; Proenzymes; Derivatives thereof
- A61K38/51—Lyases (4)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
- A61P7/04—Antihaemorrhagics; Procoagulants; Haemostatic agents; Antifibrinolytic agents
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N9/00—Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
- C12N9/88—Lyases (4.)
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K48/00—Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Organic Chemistry (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Wood Science & Technology (AREA)
- Zoology (AREA)
- Genetics & Genomics (AREA)
- Diabetes (AREA)
- Hematology (AREA)
- Biotechnology (AREA)
- Immunology (AREA)
- General Engineering & Computer Science (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Microbiology (AREA)
- Gastroenterology & Hepatology (AREA)
- Biomedical Technology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Epidemiology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Enzymes And Modification Thereof (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DK11298 | 1998-01-27 | ||
| DKPA199801748 | 1998-12-30 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| PT1049487E true PT1049487E (pt) | 2002-10-31 |
Family
ID=26063333
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| PT99906067T PT1049487E (pt) | 1998-01-27 | 1999-01-27 | Tratamento de porfiria aguda interminente (pai) e outras doencas porfiricas |
Country Status (11)
| Country | Link |
|---|---|
| EP (1) | EP1049487B1 (pt) |
| JP (1) | JP2002501032A (pt) |
| AT (1) | ATE217799T1 (pt) |
| AU (1) | AU750143B2 (pt) |
| CA (1) | CA2319096C (pt) |
| DE (1) | DE69901536T2 (pt) |
| DK (1) | DK1049487T3 (pt) |
| ES (1) | ES2177240T3 (pt) |
| NO (1) | NO327241B1 (pt) |
| PT (1) | PT1049487E (pt) |
| WO (1) | WO1999037325A2 (pt) |
Families Citing this family (11)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US6537777B1 (en) | 1998-07-27 | 2003-03-25 | Hemebiotech A/S | Human porphobilinogen deaminase sequences |
| AU774603B2 (en) * | 1999-07-27 | 2004-07-01 | Zymenex A/S | Production of rhPBGD and new therapeutic methods for treating patients with acute intermittent porphyria (AIP) and other porphyric diseases |
| EP2532742B1 (en) | 2004-01-30 | 2018-08-08 | Shire Pharmaceuticals Ireland Limited | Recombinant arylsulfatase A for reducing galatosyl sulphatide levels in a subject |
| SI2628746T1 (sl) | 2006-04-04 | 2019-04-30 | Chiesi Farmaceutici S.P.A. | Proces za koncentriranje polipeptida |
| WO2010036118A1 (en) | 2008-09-29 | 2010-04-01 | Amsterdam Molecular Therapeutics (Amt) B.V. | Porphobilinogen deaminase gene therapy |
| US10336992B2 (en) | 2011-07-08 | 2019-07-02 | Shire Human Genetic Therapies, Inc. | Methods for purification of arylsulfatase A |
| MX367842B (es) | 2012-02-07 | 2019-09-09 | Global Bio Therapeutics Inc | Método compartimentado de administración de ácidos nucleicos y composiciones y usos del mismo. |
| CA2896979C (en) | 2013-01-09 | 2023-05-02 | Shire Human Genetic Therapies, Inc. | Methods for purification of arylsulfatase a |
| DK3030163T3 (da) | 2013-08-08 | 2019-07-01 | Global Bio Therapeutics Inc | Klemmeindretning til minimalt invasive procedurer |
| CA3024624A1 (en) * | 2016-05-18 | 2017-11-23 | Modernatx, Inc. | Polynucleotides encoding porphobilinogen deaminase for the treatment of acute intermittent porphyria |
| US11390854B2 (en) | 2017-05-09 | 2022-07-19 | Fundacion Para La Investigacion Medica Aplicada | Human porphobilinogen deaminase derived proteins and polynucleotides and uses thereof |
Family Cites Families (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2657345B2 (ja) * | 1992-04-17 | 1997-09-24 | 新日本製鐵株式会社 | 医療用診断装置および疾患判断方法 |
-
1999
- 1999-01-27 JP JP2000528305A patent/JP2002501032A/ja active Pending
- 1999-01-27 PT PT99906067T patent/PT1049487E/pt unknown
- 1999-01-27 ES ES99906067T patent/ES2177240T3/es not_active Expired - Lifetime
- 1999-01-27 WO PCT/DK1999/000040 patent/WO1999037325A2/en active IP Right Grant
- 1999-01-27 DK DK99906067T patent/DK1049487T3/da active
- 1999-01-27 AU AU26097/99A patent/AU750143B2/en not_active Expired
- 1999-01-27 EP EP99906067A patent/EP1049487B1/en not_active Expired - Lifetime
- 1999-01-27 DE DE69901536T patent/DE69901536T2/de not_active Expired - Lifetime
- 1999-01-27 CA CA002319096A patent/CA2319096C/en not_active Expired - Lifetime
- 1999-01-27 AT AT99906067T patent/ATE217799T1/de active
-
2000
- 2000-07-26 NO NO20003830A patent/NO327241B1/no not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| ES2177240T3 (es) | 2002-12-01 |
| ATE217799T1 (de) | 2002-06-15 |
| NO20003830L (no) | 2000-09-27 |
| EP1049487A2 (en) | 2000-11-08 |
| CA2319096C (en) | 2007-07-03 |
| DK1049487T3 (da) | 2002-09-16 |
| DE69901536D1 (de) | 2002-06-27 |
| DE69901536T2 (de) | 2003-01-16 |
| AU2609799A (en) | 1999-08-09 |
| WO1999037325A2 (en) | 1999-07-29 |
| JP2002501032A (ja) | 2002-01-15 |
| EP1049487B1 (en) | 2002-05-22 |
| AU750143B2 (en) | 2002-07-11 |
| WO1999037325A3 (en) | 1999-09-30 |
| NO20003830D0 (no) | 2000-07-26 |
| CA2319096A1 (en) | 1999-07-29 |
| NO327241B1 (no) | 2009-05-18 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT1049487E (pt) | Tratamento de porfiria aguda interminente (pai) e outras doencas porfiricas | |
| Shazly et al. | Release of antioxidant peptides from buffalo and bovine caseins: Influence of proteases on antioxidant capacities | |
| WO2003089456A3 (en) | Peptide inhibitors of protein kinase c | |
| ATE340560T1 (de) | Verfahren und zusammensetzungen für nichtvirale gentherapie zur behandlung von hyperproliferativen krankheiten | |
| DK1661909T3 (da) | Biologisk ikke-nedbrydeligt peptid, angiotensinomdannende enzyminhibitor, medikament og funktionel fødevare | |
| BR9809921A (pt) | Método para admistração de composição de microorganismos viáveis para aves domésticas | |
| BR0307871A (pt) | Proteìnas contendo domìnio de folistatina | |
| MX9207449A (es) | Inhibidores de la enzima proteolitica derivada de sacarina. | |
| RU2010150428A (ru) | Композиции для усиления антибактериальной активности миелопероксидазы и способы их применения | |
| Schallreuter et al. | In VivoEvidence for Compromised Phenylalanine Metabolism in Vitiligo | |
| BR112019020367A2 (pt) | modulação da expressão do gene para sirtuína com decapeptídeo-12 em progenitores de queratinócito epidérmico | |
| ATE337712T1 (de) | Zusammensetzung zur intestinalen verabreichung | |
| Kusakabe et al. | Occurrence of a novel enzyme, L-lysine oxidase with antitumor activity in culture extract of Trichoderma viride | |
| EA200501413A1 (ru) | Местные композиции, содержащие l-карнитин | |
| US20150290108A1 (en) | Cosmetic composition | |
| ATE315084T1 (de) | Herstellung von rhpbgd | |
| ATE487390T1 (de) | Proteinzusammensetzung zur behandlung eines physiologisch bedingten, klinisch unauffälligen proteinmehrbedarfs | |
| WO2002092014A3 (en) | Destruction of prions using vibriolysin or variants thereof | |
| Oh et al. | Hypolipidemic and antiinflammatory effects of fermented Maillard reaction products by Lactobacillus fermentum H9 in an animal model | |
| Abe et al. | Some properties of a cysteine proteinase inhibitor from corn endosperm | |
| Borsook | Enzymatic syntheses of peptide bonds | |
| Van Berlo et al. | γ-Aminobutyric acid production in small and large intestine of normal and germfree Wistar rats: Influence of food intake and intestinal flora | |
| ATE312179T1 (de) | Serin-threonin-kinase enthaltendes mittel zur tumortherapie und tumordiagnose | |
| KR20220041119A (ko) | 노화의 진행 억제제, 및 이를 포함하는 음식품 | |
| Millán | What can we learn about the neural functions of TNAP from studies on other organs and tissues? |